1. Abu-Soud HM, Wang J, Rousseau DL, Fukuto JM, Ignarro, LJ, & Stuehr DJ. 1995. Neuronal nitric oxide synthase self-inactivates by forming a ferrous-nitrosyl complex during aerobic catalysis. J Biol Chem 270:22997–23006.
2. Aisaka K, Gross SS, Griffith OW, & Levi R. 1989. NG-Methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo? Biochem Biophys Res Commun 750:881–886.
3. Axelsson KL, Anderson RGG, & Wikberg JES. 1982. Vascular smooth muscle relaxation by nitro compounds: reduced relaxation and cGMP elevation in tolerant vessels and reversal of tolerance by dithiothreitol. Ada Pharmacol Toxicol 50:350–351.
4. Axelsson KL, & Andersson RG. 1983. Tolerance towards nitroglycerin, induced in vivo, is correlated to a reduced cGMP response and an alteration in cGMP turnover. Eur J Pharmacol 88:11–19.
5. Ayajiki K, Kindermann M, Hecker M, Fleming I, & Busse R. 1996. Intracellular pH andtyrosine phosphorylation but not calcium determine shear stress-induced nitric oxide production in native endothelial cells. Circ Res 75:750–758.